Medistim

Earnings Release • Feb 17, 2017

Results for fourth quarter and preliminary results for 2016 for Medistim

Results for fourth quarter and preliminary results for 2016 for Medistim

Sales for the quarter ended at MNOK 67.4 (MNOK 74.6). Sales

for 2016 ended at MNOK 268.1 (MNOK 251.4), a growth of 6.6 %.

For the year 20 MNOK of sales is lost related to the

Medtronic products. Currency neutral sales of own products

decreased with 3 MNOK or 5.7 % and was influenced by a back

order situation for the flow probes. For the year currency

neutral sales of own products increased with 9.5 %.

Operating profit (EBIT) for the quarter ended at MNOK 9.7

(MNOK 16.0). Operating profit for 2016 ended at MNOK 56.4

(MNOK 50.3). The Board suggests a dividend of NOK 1.75 per

share (NOK 1.65).

Continued strong development in the US where currency

neutral growth in sales was 13.4 %. For 2016 currency

neutral growth was 14.2 % .

Medistim launch of the New SonoQ product in India in the

fourth quarter.